A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 11, 2025

Primary Completion Date

January 12, 2026

Study Completion Date

January 12, 2026

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

NNC0471-0119 H

NNC0471-0119 H will be administered subcutaneously.

DRUG

Insulin Aspart

Insulin aspart will be administered subcutaneously.

Trial Locations (1)

RECRUITING

Profil Institut für Stoffwechselforschung GmbH, Neuss